<?xml version="1.0" encoding="UTF-8" standalone="yes"?><?xml-stylesheet type="text/xsl" href="/oai-pmh-repository/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2026-10-15T15:31:25Z</responseDate>
    <request verb="GetRecord" identifier="oai:data.mendeley.com/hhv937v7pv.2" metadataPrefix="oai_dc">https://data.mendeley.com/oai</request>
    <GetRecord>
        <record>
            <header>
                <identifier>oai:data.mendeley.com/hhv937v7pv.2</identifier>
                <datestamp>2025-03-27T14:54:49Z</datestamp>
            </header>
            <metadata><oai_dc:dc xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <dc:creator>Budi Susilo, Yudi Kurniawan</dc:creator>
    <dc:title>Artificial Intelligence-Powered Precision Medicine for Cardi-ovascular Disease Prevention and Management</dc:title>
    <dc:publisher>Mendeley Data</dc:publisher>
    <dc:description>Abstract
Artificial intelligence (AI) is transforming precision medicine, particularly in cardiovascular disease prevention and management. This bibliometric analysis examines the research land-scape from 2020 to 2024, focusing on AI&apos;s role in improving diagnostics, personalizing treatment, and advancing predictive healthcare. Using the PRISMA framework, VOSviewer, Harzing&apos;s Publish or Perish, and Excel, 137 articles from Scopus were systematically ana-lyzed. The study reveals a significant surge in research activity, with 2024 marking a peak. Machine learning and deep learning are central to key advancements, enabling early detec-tion and risk prediction. Contributions from leading institutions highlight the global and in-terdisciplinary nature of this field, with studies demonstrating AI&apos;s potential to integrate complex datasets and deliver tailored therapies. While AI-driven innovations show promise, challenges such as ethical concerns and healthcare disparities remain. This analysis under-scores AI&apos;s transformative potential in precision medicine and identifies opportunities for equitable, collaborative advancements.

Keywords: Artificial Intelligence, Machine Learning, Cardiovascular Disease, Heart Dis-ease, Coronary Artery Disease, Precision Medicine, Treatment
 
</dc:description>
    <dc:subject>Artificial Intelligence</dc:subject>
    <dc:subject>Machine Learning</dc:subject>
    <dc:subject>Cardiovascular Disease</dc:subject>
    <dc:subject>Combined Treatment</dc:subject>
    <dc:subject>Heart Disease</dc:subject>
    <dc:subject>Coronary Artery Disease</dc:subject>
    <dc:subject>Precision Medicine</dc:subject>
    <dc:type>Dataset</dc:type>
    <dc:identifier>doi:10.17632/hhv937v7pv.2</dc:identifier>
    <dc:identifier>oai:data.mendeley.com/hhv937v7pv.2</dc:identifier>
    <dc:rights>Creative Commons Attribution 4.0 International</dc:rights>
    <dc:rights>http://creativecommons.org/licenses/by/4.0</dc:rights>
    <dc:relation>https://data.mendeley.com/datasets/hhv937v7pv</dc:relation>
    <dc:date>2025-03-27T14:54:49Z</dc:date>
</oai_dc:dc></metadata>
        </record>
    </GetRecord>
</OAI-PMH>
